Quoin Pharmaceuticals, Ltd. (NasdaqCM:QNRX) is looking for M&A opportunities. Michael Myers, Chief Executive Officer said, "As discussed, given our strong balance sheet and potential access to additional capital, we have been acutely focused on expanding our product portfolio via acquisition, in-licensing or other means. We continue to search for M&A opportunities, and it remains a priority for us, but I do want to caution that we will not execute the deal unless it really makes sense for us as a company to do so".